Peptide therapy can support fat loss, muscle recovery, energy levels, hormone balance, injury healing, and overall performance
These 5 residues bind glutathione (GSH) and are only present in GPx1
The New England Journal of Medicine, 373 (1), 1122
[1] The most frequently reported gastrointestinal side effects include: Nausea (very common, affecting more than 1 in 10 patients) Diarrhoea (very common, affecting more than 1 in 10 patients) Vomiting (common to very common, depending on dose) Decreased appetite (very common) Constipation Abdominal pain or discomfort Dyspepsia (indigestion) Belching , which may occasionally have a sulphurous odour These symptoms typically occur because GLP-1 receptor agonists slow gastric emptyingthe rate at which food leaves the stomachand alter gastrointestinal motility
Mounjaro activates GIP and GLP-1 receptors